Award
National Institutes of Health 1F30AI197786-01
Investigating the Development of Tregs from iPSCs by Manipulating Exogenous and Endogenous FOXP3 Expression
Recipient
University of California Los Angeles, Department of Pathology
Award Amount
$43,058.00
Ceiling
$43,058.00
Awarded
March 30, 2026
Identifier
1F30AI197786-01
NIH awarded a research grant to UCLA for studying Tregs development from iPSCs by manipulating FOXP3 expression, aimed at advancing autoimmune disease therapy.
Description
A research grant opportunity from NIH focused on T cell regulation and autoimmune disease therapy involving advanced stem cell and gene editing techniques. The award is for a multi-year period from 2026 to 2030. The primary investigator is Anthony Azzun at UCLA.